Deerfield Mgmt, L.P. 13D and 13G filings for BioCryst Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-09-19 12:23 pm Purchase | 2025-09-12 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | Deerfield Mgmt, L.P. | 12,169,000 5.800% | 5,793,857 (+90.88%) | Filing |